Crizotinib Interactions
There are 811 drugs known to interact with crizotinib, along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 316 are major, 478 are moderate, and 17 are minor.
- View all 811 medications that may interact with crizotinib
- View crizotinib alcohol/food interactions (1)
- View crizotinib disease interactions (7)
Most frequently checked interactions
View interaction reports for crizotinib and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Activated Charcoal (charcoal)
- Actos (pioglitazone)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Aleve (naproxen)
- Altace (ramipril)
- Ambien (zolpidem)
- Aredia (pamidronate)
- Arixtra 5 mg/dose (fondaparinux)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- Azithromycin Dose Pack (azithromycin)
- Benadryl (diphenhydramine)
- Benicar (olmesartan)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Crestor (rosuvastatin)
- Glycerol (glycerin)
- Heparin Sodium (heparin)
- Metoprolol Succinate ER (metoprolol)
- Nexium (esomeprazole)
- Quercetin (bioflavonoids)
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zoloft (sertraline)
Crizotinib alcohol/food interactions
There is 1 alcohol/food interaction with crizotinib.
Crizotinib disease interactions
There are 7 disease interactions with crizotinib which include:
- bradycardia
- gastrointestinal perforation
- hepatic impairment
- ILD/pneumonitis
- QT prolongation
- renal impairment
- visual loss
Report options
More about crizotinib
- crizotinib consumer information
- Compare alternatives
- Reviews (8)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Tagrisso
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose ...
Xalkori
Xalkori (crizotinib) is an oral kinase inhibitor, available in capsules or pellets, that may be ...
Docetaxel
Docetaxel systemic is used for breast cancer, breast cancer, metastatic, gastric cancer, head and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
